HIV-1 reactivation induced by the periodontal pathogens Fusobacterium nucleatum and Porphyromonas gingivalis involves toll-like receptor 4 and 9 activation in monocytes/macrophages

Clinical and Vaccine Immunology

Volumn 17, Issue 9, 2010, Pages 1417-1427

  González, Octavio A ^a   Li, Mengtao ^a   Ebersole, Jeffrey L ^a   Huang, Chifu B ^a  

^a UNIVERSITY OF KENTUCKY COLLEGE OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR SP1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; AUTOCRINE EFFECT; BIOLOGICAL MODEL; CELL LINE; CYTOKINE PRODUCTION; FUSOBACTERIUM NUCLEATUM; GENE ACTIVATION; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; MACROPHAGE; MONOCYTE; NONHUMAN; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROMOTER REGION; VIRUS LATENCY; VIRUS REACTIVATION;

CELL LINE; FUSOBACTERIUM NUCLEATUM; HIV-1; HUMANS; INTERLEUKIN-1BETA; MONOCYTES; NF-KAPPA B; PORPHYROMONAS GINGIVALIS; SP1 TRANSCRIPTION FACTOR; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR-ALPHA; VIRUS ACTIVATION;

EID: 77956415765     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00009-10     Document Type: Article

References (77)

1. +n patients. Arch. Oral Biol. 52:1102-1108.
2. Alpagot, T., V. Suzara, and M. Bhattacharyya. 2006. The associations between gingival crevice fluid matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and periodontitis in human immunodeficiency virus-positive patients. J. Periodontal Res. 41:491-497.
3. Amini, S., M. Saunders, K. Kelley, K. Khalili, and B. E. Sawaya. 2004. Interplay between HIV-1 Vpr and Sp1 modulates p21(WAF1) gene expression in human astrocytes. J. Biol. Chem. 279:46046-46056.
4. Báfica, A., C. A. Scanga, M. L. Schito, S. Hieny, and A. Sher. 2003. Cutting edge: in vivo induction of integrated HIV-1 expression by mycobacteria is critically dependent on Toll-like receptor 2. J. Immunol. 171:1123-1127.
5. Beutler, B. A. 2009. TLRs and innate immunity. Blood 113:1399-1407.
6. Biswas, P., B. Mantelli, F. Delfanti, M. Cota, G. Vallanti, C. de Filippi, M. Mengozzi, E. Vicenzi, A. Lazzarin, and G. Poli. 2001. Tumor necrosis factoralpha drives HIV-1 replication in U937 cell clones and upregulates CXCR4. Cytokine 13:55-59.
7. Blanchard, A., L. Montagnier, and M. L. Gougeon. 1997. Influence of microbial infections on the progression of HIV disease. Trends Microbiol. 5:326-331.
8. Bode, K. A., F. Schmitz, L. Vargas, K. Heeg, and A. H. Dalpke. 2009. Kinetic of RelA activation controls magnitude of TLR-mediated IL-12p40 induction. J. Immunol. 182:2176-2184.
9. Brady, J., and F. Kashanchi. 2005. Tat gets the "green" light on transcription initiation. Retrovirology 2:69.
10. Brenchley, J. M., D. A. Price, T. W. Schacker, T. E. Asher, G. Silvestri, S. Rao, Z. Kazzaz, E. Bornstein, O. Lambotte, D. Altmann, B. R. Blazar, B. Rodriguez, L. Teixeira-Johnson, A. Landay, J. N. Martin, F. M. Hecht, L. J. Picker, M. M. Lederman, S. G. Deeks, and D. C. Douek. 2006. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12:1365-1371.
11. Brenchley, J. M., T. W. Schacker, L. E. Ruff, D. A. Price, J. H. Taylor, G. J. Beilman, P. L. Nguyen, A. Khoruts, M. Larson, A. T. Haase, and D. C. Douek. 2004. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200:749-759.
12. Bush, C. E., R. M. Donovan, N. P. Markowitz, P. Kvale, and L. D. Saravolatz. 1996. A study of HIV RNA viral load in AIDS patients with bacterial pneumonia. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13:23-26.
13. Cahill, R. J., S. Tan, G. Dougan, P. O'Gaora, D. Pickard, N. Kennea, M. H. Sullivan, R. G. Feldman, and A. D. Edwards. 2005. Universal DNA primers amplify bacterial DNA from human fetal membranes and link Fusobacterium nucleatum with prolonged preterm membrane rupture. Mol. Hum. Reprod. 11:761-766.
14. Carmody, R. J., and Y. H. Chen. 2007. Nuclear factor-kappaB: activation and regulation during Toll-like receptor signaling. Cell. Mol. Immunol. 4:31-41.
15. Chattopadhyay, A., D. J. Caplan, G. D. Slade, D. C. Shugars, H. C. Tien, and L. L. Patton. 2005. Risk indicators for oral candidiasis and oral hairy leukoplakia in HIV-infected adults. Community Dent. Oral Epidemiol. 33:35-44.
16. Chen, A., I. C. Boulton, J. Pongoski, A. Cochrane, and S. D. Gray-Owen. 2003. Induction of HIV-1 long terminal repeat-mediated transcription by Neisseria gonorrhoeae. AIDS 17:625-628.
17. Chun, R. F., O. J. Semmes, C. Neuveut, and K. T. Jeang. 1998. Modulation of Sp1 phosphorylation by human immunodeficiency virus type 1 Tat. J. Virol. 72:2615-2629.
18. Coogan, M. M., J. Greenspan, and S. J. Challacombe. 2005. Oral lesions in infection with human immunodeficiency virus. Bull. World Health Organ. 83:700-706.
19. Dalpke, A., J. Frank, M. Peter, and K. Heeg. 2006. Activation of Toll-like receptor 9 by DNA from different bacterial species. Infect. Immun. 74:940-946.
20. Devadas, K., N. J. Hardegen, L. M. Wahl, I. K. Hewlett, K. A. Clouse, K. M. Yamada, and S. Dhawan. 2004. Mechanisms for macrophage-mediated HIV-1 induction. J. Immunol. 173:6735-6744.
21. Ebersole, J. L., M. J. Novak, B. S. Michalowicz, J. S. Hodges, M. J. Steffen, J. E. Ferguson, A. Diangelis, W. Buchanan, D. A. Mitchell, and P. N. Papapanou. 2009. Systemic immune responses in pregnancy and periodontitis: relationship to pregnancy outcomes in the Obstetrics and Periodontal Therapy (OPT) Study. J. Periodontol. 80:953-960.
22. Equils, O., E. Faure, L. Thomas, Y. Bulut, S. Trushin, and M. Arditi. 2001. Bacterial lipopolysaccharide activates HIV long terminal repeat through Toll-like receptor 4. J. Immunol. 166:2342-2347.
23. Equils, O., Z. Madak, C. Liu, K. S. Michelsen, Y. Bulut, and D. Lu. 2004. Rac1 and Toll-IL-1 receptor domain-containing adapter protein mediate Toll-like receptor 4 induction of HIV-long terminal repeat. J. Immunol. 172:7642-7646. (Pubitemid 38747629)
24. Ewaschuk, J. B., J. L. Backer, T. A. Churchill, F. Obermeier, D. O. Krause, and K. L. Madsen. 2007. Surface expression of Toll-like receptor 9 is up-regulated on intestinal epithelial cells in response to pathogenic bacterial DNA. Infect. Immun. 75:2572-2579.
25. Felber, B. K., and G. N. Pavlakis. 1988. A quantitative bioassay for HIV-1 based on trans-activation. Science 239:184-187.
26. Gibson, F. C., III, T. Ukai, and C. A. Genco. 2008. Engagement of specific innate immune signaling pathways during Porphyromonas gingivalis induced chronic inflammation and atherosclerosis. Front. Biosci. 13:2041-2059.
27. González, O. A., J. L. Ebersole, and C. B. Huang. 2009. Oral infectious diseases: a potential risk factor for HIV virus recrudescence? Oral Dis. 15:313-327.
28. Greenspan, D., E. Komaroff, M. Redford, J. A. Phelan, M. Navazesh, M. E. Alves, H. Kamrath, R. Mulligan, C. E. Barr, and J. S. Greenspan. 2000. Oral mucosal lesions and HIV viral load in the Women's Interagency HIV Study (WIHS). J. Acquir. Immune Defic. Syndr. 25:44-50.
29. + T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J. Virol. 77:11708-11717.
30. Hajishengallis, G., R. I. Tapping, E. Harokopakis, S. Nishiyama, P. Ratti, R. E. Schifferle, E. A. Lyle, M. Triantafilou, K. Triantafilou, and F. Yoshimura. 2006. Differential interactions of fimbriae and lipopolysaccharide from Porphyromonas gingivalis with the Toll-like receptor 2-centred pattern recognition apparatus. Cell. Microbiol. 8:1557-1570.
31. Han, Y. W., R. W. Redline, M. Li, L. Yin, G. B. Hill, and T. S. McCormick. 2004. Fusobacterium nucleatum induces premature and term stillbirths in pregnant mice: implication of oral bacteria in preterm birth. Infect. Immun. 72:2272-2279.
32. Herbein, G., A. Varin, A. Larbi, C. Fortin, U. Mahlknecht, T. Fulop, and B. B. Aggarwal. 2008. Nef and TNFalpha are coplayers that favor HIV-1 replication in monocytic cells and primary macrophages. Curr. HIV Res. 6:117-129.
33. Hill, G. B. 1998. Preterm birth: associations with genital and possibly oral microflora. Ann. Periodontol. 3:222-232.
34. Holst, E., A. R. Goffeng, and B. Andersch. 1994. Bacterial vaginosis and vaginal microorganisms in idiopathic premature labor and association with pregnancy outcome. J. Clin. Microbiol. 32:176-186.
35. Huang, C. B., K. A. Emerson, O. A. Gonzalez, and J. L. Ebersole. 2009. Oral bacteria induce a differential activation of human immunodeficiency virus-1 promoter in T cells, macrophages and dendritic cells. Oral Microbiol. Immunol. 24:401-407.
36. Imai, K., K. Ochiai, and T. Okamoto. 2009. Reactivation of latent HIV-1 infection by the periodontopathic bacterium Porphyromonas gingivalis involves histone modification. J. Immunol. 182:3688-3695.
37. Ishihara, K., A. Nabuchi, R. Ito, K. Miyachi, H. K. Kuramitsu, and K. Okuda. 2004. Correlation between detection rates of periodontopathic bacterial DNA in stenotic artery plaque and in dental plaque samples. J. Clin. Microbiol. 42:1313-1315. (Erratum, 42:5437.)
38. Jacqué, J. M., B. Fernandez, F. Arenzana-Seisdedos, D. Thomas, F. Baleux, J. L. Virelizier, and F. Bachelerie. 1996. Permanent occupancy of the human immunodeficiency virus type 1 enhancer by NF-kappa B is needed for persistent viral replication in monocytes. J. Virol. 70:2930-2938.
39. Ji, S., J. Hyun, E. Park, B. L. Lee, K. K. Kim, and Y. Choi. 2007. Susceptibility of various oral bacteria to antimicrobial peptides and to phagocytosis by neutrophils. J. Periodontal Res. 42:410-419.
40. Jiang, G., A. Espeseth, D. J. Hazuda, and D. M. Margolis. 2007. c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter. J. Virol. 81:10914-10923.
41. Jiang, W., M. M. Lederman, P. Hunt, S. F. Sieg, K. Haley, B. Rodriguez, A. Landay, J. Martin, E. Sinclair, A. I. Asher, S. G. Deeks, D. C. Douek, and J. M. Brenchley. 2009. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J. Infect. Dis. 199:1177-1185.
42. Kawai, T., and S. Akira. 2007. Signaling to NF-kappaB by Toll-like receptors. Trends Mol. Med. 13:460-469.
43. Kawai, T., and S. Akira. 2006. TLR signaling. Cell Death Differ. 13:816-825.
44. Kesavalu, L., S. C. Holt, and J. L. Ebersole. 2003. In vitro environmental regulation of Porphyromonas gingivalis growth and virulence. Oral Microbiol. Immunol. 18:226-233.
45. Kikkert, R., M. L. Laine, L. A. Aarden, and A. J. van Winkelhoff. 2007. Activation of toll-like receptors 2 and 4 by gram-negative periodontal bacteria. Oral Microbiol. Immunol. 22:145-151.
46. Kitaura, H., N. Ohara, K. Kobayashi, and T. Yamada. 2001. TNF-alpha-mediated multiplication of human immunodeficiency virus in chronically infected monocytoid cells by mycobacterial infection. APMIS 109:533-540. (Pubitemid 32844261)
47. Kozarov, E. V., B. R. Dorn, C. E. Shelburne, W. A. Dunn, Jr., and A. Progulske-Fox. 2005. Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Arterioscler. Thromb. Vasc. Biol. 25:e17-18.
48. Kroidl, A., A. Schaeben, M. Oette, M. Wettstein, A. Herfordt, and D. Haussinger. 2005. Prevalence of oral lesions and periodontal diseases in HIV-infected patients on antiretroviral therapy. Eur. J. Med. Res. 10:448-453.
49. Kutsch, O., E. N. Benveniste, G. M. Shaw, and D. N. Levy. 2002. Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency. J. Virol. 76:8776-8786.
50. Liu, H., R. W. Redline, and Y. W. Han. 2007. Fusobacterium nucleatum induces fetal death in mice via stimulation of TLR4-mediated placental inflammatory response. J. Immunol. 179:2501-2508.
51. Majello, B., P. De Luca, G. Hagen, G. Suske, and L. Lania. 1994. Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1. Nucleic Acids Res. 22:4914-4921.
52. Makiura, N., M. Ojima, Y. Kou, N. Furuta, N. Okahashi, S. Shizukuishi, and A. Amano. 2008. Relationship of Porphyromonas gingivalis with glycemic level in patients with type 2 diabetes following periodontal treatment. Oral Microbiol. Immunol. 23:348-351.
53. Miyazato, A., K. Nakamura, N. Yamamoto, H. M. Mora-Montes, M. Tanaka, Y. Abe, D. Tanno, K. Inden, X. Gang, K. Ishii, K. Takeda, S. Akira, S. Saijo, Y. Iwakura, Y. Adachi, N. Ohno, K. Mitsutake, N. A. Gow, M. Kaku, and K. Kawakami. 2009. Toll-like receptor 9-dependent activation of myeloid dendritic cells by deoxynucleic acids from Candida albicans. Infect. Immun. 77:3056-3064.
54. Nicol, M. Q., J. M. Mathys, A. Pereira, K. Ollington, M. H. Ieong, and P. R. Skolnik. 2008. Human immunodeficiency virus infection alters tumor necrosis factor alpha production via Toll-like receptor-dependent pathways in alveolar macrophages and U1 cells. J. Virol. 82:7790-7798.
55. Nokta, M. 2008. Oral manifestations associated with HIV infection. Curr. HIV/AIDS Rep. 5:5-12.
56. Nonnenmacher, C., A. Dalpke, S. Zimmermann, L. Flores-De-Jacoby, R. Mutters, and K. Heeg. 2003. DNA from periodontopathogenic bacteria is immunostimulatory for mouse and human immune cells. Infect. Immun. 71:850-856.
57. Nordone, S. K., G. A. Ignacio, L. Su, G. D. Sempowski, D. T. Golenbock, L. Li, and G. A. Dean. 2007. Failure of TLR4-driven NF-kappa B activation to stimulate virus replication in models of HIV type 1 activation. AIDS Res. Hum. Retroviruses 23:1387-1395.
58. Osiecki, K., L. Xie, J. H. Zheng, R. Squires, M. Pettoello-Mantovani, and H. Goldstein. 2005. Identification of granulocyte-macrophage colony-stimulating factor and lipopolysaccharide-induced signal transduction pathways that synergize to stimulate HIV type 1 production by monocytes from HIV type 1 transgenic mice. AIDS Res. Hum. Retroviruses 21:125-139.
59. Patton, L. L. 2000. Sensitivity, specificity, and positive predictive value of oral opportunistic infections in adults with HIV/AIDS as markers of immune suppression and viral burden. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 90:182-188.
60. Pereira, L. A., K. Bentley, A. Peeters, M. J. Churchill, and N. J. Deacon. 2000. A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter. Nucleic Acids Res. 28:663-668.
61. Poli, G., P. Bressler, A. Kinter, E. Duh, W. C. Timmer, A. Rabson, J. S. Justement, S. Stanley, and A. S. Fauci. 1990. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms. J. Exp. Med. 172:151-158.
62. Pomerantz, R. J., M. B. Feinberg, D. Trono, and D. Baltimore. 1990. Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression. J. Exp. Med. 172:253-261.
63. Rohr, O., C. Marban, D. Aunis, and E. Schaeffer. 2003. Regulation of HIV-1 gene transcription: from lymphocytes to microglial cells. J. Leukoc. Biol. 74:736-749.
64. Rossi, A., R. Mukerjee, P. Ferrante, K. Khalili, S. Amini, and B. E. Sawaya. 2006. Human immunodeficiency virus type 1 Tat prevents dephosphorylation of Sp1 by TCF-4 in astrocytes. J. Gen. Virol. 87:1613-1623.
65. Sgarbanti, M., A. L. Remoli, G. Marsili, B. Ridolfi, A. Borsetti, E. Perrotti, R. Orsatti, R. Ilari, L. Sernicola, E. Stellacci, B. Ensoli, and A. Battistini. 2008. IRF-1 is required for full NF-kappaB transcriptional activity at the human immunodeficiency virus type 1 long terminal repeat enhancer. J. Virol. 82:3632-3641.
66. Socransky, S. S., and A. D. Haffajee. 2005. Periodontal microbial ecology. Periodontol. 2000 38:135-187.
67. Stevenson, M. 2003. HIV-1 pathogenesis. Nat. Med. 9:853-860.
68. Stojanova, A., C. Caro, R. J. Jarjour, S. K. Oster, L. Z. Penn, and R. J. Germinario. 2004. Repression of the human immunodeficiency virus type-1 long terminal repeat by the c-Myc oncoprotein. J. Cell. Biochem. 92:400-413.
69. Swingler, S., A. Mann, J. Jacque, B. Brichacek, V. G. Sasseville, K. Williams, A. A. Lackner, E. N. Janoff, R. Wang, D. Fisher, and M. Stevenson. 1999. HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages. Nat. Med. 5:997-1003.
70. Tada, H., S. Aiba, K. Shibata, T. Ohteki, and H. Takada. 2005. Synergistic effect of Nod1 and Nod2 agonists with Toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells. Infect. Immun. 73:7967-7976.
71. Takeshita, A., K. Imai, and S. Hanazawa. 1999. CpG motifs in Porphyromonas gingivalis DNA stimulate interleukin-6 expression in human gingival fibroblasts. Infect. Immun. 67:4340-4345.
72. Tietze, K., A. Dalpke, S. Morath, R. Mutters, K. Heeg, and C. Nonnenmacher. 2006. Differences in innate immune responses upon stimulation with gram-positive and gram-negative bacteria. J. Periodontal Res. 41:447-454.
73. Wahl, S. M., T. Greenwell-Wild, G. Peng, G. Ma, J. M. Orenstein, and N. Vazquez. 2003. Viral and host cofactors facilitate HIV-1 replication in macrophages. J. Leukoc. Biol. 74:726-735.
74. Wig, N., P. Anupama, S. Singh, R. Handa, P. Aggarwal, S. N. Dwivedi, B. L. Jailkhani, and J. P. Wali. 2005. Tumor necrosis factor-alpha levels in patients with HIV with wasting in South Asia. AIDS Patient Care STDS 19:212-215.
75. Williams, S. A., H. Kwon, L. F. Chen, and W. C. Greene. 2007. Sustained induction of NF-kappa B is required for efficient expression of latent human immunodeficiency virus type 1. J. Virol. 81:6043-6056.
76. Yedavalli, V. S., M. Benkirane, and K. T. Jeang. 2003. Tat and transactivation-responsive (TAR) RNA-independent induction of HIV-1 long terminal repeat by human and murine cyclin T1 requires Sp1. J. Biol. Chem. 278:6404-6410.
77. Zhong, B., P. Tien, and H. B. Shu. 2006. Innate immune responses: crosstalk of signaling and regulation of gene transcription. Virology 352:14-21.